Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
BMC Gastroenterol. 2012 Aug 16;12:109. doi: 10.1186/1471-230X-12-109.
Controversy exists regarding the role of PD1 and its ligand PD-L1 in chronic hepatitis B infection. In some studies, persistent HBV infection has been attributed to high levels of PD-1 and PD-L1 expression on HBV-specific T-cells and antigen-presenting cells (APCs) respectively. Other studies revealed that the up-regulation of PD-1 and PD-L1 during an acute inflammation phase is required to offset increasing positive co-stimulatory signals to avoid severe damage by an over-vigorous immune response.
Fifteen chronic hepatitis B patients, with inflammatory flare episode, were recruited prospectively. Based on serum HBV-DNA, HBsAg load, and ALT values, inflammatory flare episode were divided into initial, climax, decline and regression phase. Blood sample and liver biopsy tissues from each individual were taken in these 4 phases respectively. Circulating and intra-hepatic PD1 and PD-L1 expression levels were monitored throughout the inflammatory flare episode by flow cytometry and immunostaining and these expression levels were related to the HBV-specific T-cell changes, expression of pro-inflammatory cytokines, HBV-DNA replication and HBV antigen load.
]The levels of PD-1 and PD-L1 expressions were significantly up-regulated in the inflammation ascending phase, initial and climax period and in parallel with HBV-specific colon expansion. It showed increasing the level of serum ALT and decreasing the HBV-DNA loads. As the level of inflammation reduced, the circulating and intra-hepatic PD1 and circulating PD-L1 decreased progressively in concordance with serum ALT, HBV-DNA and HBsAg loads decreased except intra-hepatic PD-1 expression. Intra-hepatic PD-L1 expression did not decrease significantly during the regression phase of inflammation compared to that in prior period. The intra-hepatic PD-L1 expression remained relatively on higher level when serum HBV-DNA load and ALT decreased to approximately normal range.
The relatively high level of intra-hepatic PD-L1 expression during the inflammatory regression period may contribute to constitute an immunosuppressive microenvironment, which facilitate persistent HBV infection via the inhibition of HBV-specific T cell clonal expansion.
PD1 及其配体 PD-L1 在慢性乙型肝炎感染中的作用存在争议。在一些研究中,持续的 HBV 感染归因于 HBV 特异性 T 细胞和抗原呈递细胞(APCs)上 PD-1 和 PD-L1 的高表达。其他研究表明,在急性炎症阶段 PD-1 和 PD-L1 的上调是必需的,以抵消正协同刺激信号的增加,避免过度活跃的免疫反应造成严重损伤。
前瞻性招募了 15 名患有炎症发作的慢性乙型肝炎患者。根据血清 HBV-DNA、HBsAg 载量和 ALT 值,将炎症发作分为初始期、高峰期、下降期和消退期。在这 4 个阶段分别采集每个个体的血液样本和肝活检组织。通过流式细胞术和免疫染色监测整个炎症发作期间循环和肝内 PD1 和 PD-L1 的表达水平,这些表达水平与 HBV 特异性 T 细胞变化、促炎细胞因子表达、HBV-DNA 复制和 HBV 抗原载量相关。
PD-1 和 PD-L1 的表达水平在炎症上升期、初始期和高峰期显著上调,与 HBV 特异性扩增平行。它表现为血清 ALT 水平升高,HBV-DNA 载量降低。随着炎症水平的降低,循环和肝内 PD1 和循环 PD-L1 逐渐降低,与血清 ALT、HBV-DNA 和 HBsAg 载量降低一致,除了肝内 PD-1 表达外。与前一时期相比,炎症消退期肝内 PD-L1 表达没有显著降低。当血清 HBV-DNA 载量和 ALT 降低至接近正常范围时,肝内 PD-L1 表达仍保持在相对较高水平。
炎症消退期肝内 PD-L1 表达水平相对较高,可能有助于构成免疫抑制微环境,通过抑制 HBV 特异性 T 细胞克隆扩增,促进持续的 HBV 感染。